Animal Sedative Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine), By Route of Administration (Oral, Parenteral), By Region, By Competition
Global Animal Sedative Market has valued at USD 121.11 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.30% through 2028. The animal sedative market saw a notable disruption during the initial phase of the COVID-19 pandemic. This was primarily due to the extensive implementation of containment measures like lockdowns and social distancing by governments worldwide, which significantly reduced the operations of veterinary hospitals and pharmacies. For instance, a study conducted by Faunalytics in December 2022 revealed that in order to prevent disease transmission during the pandemic, approximately 70% of clinics in the United States and Canada temporarily suspended public access, leading to situations where animals had to attend appointments without their owners or guardians.
Key Market Drivers
Increasing Pet Ownership
Pet ownership has become a global phenomenon, with millions of households worldwide welcoming furry, feathered, or scaly companions into their lives. This surge in pet ownership is not just about companionship; it's also driving growth in various industries, including veterinary care and pharmaceuticals.
As more people open their homes to pets, there is a growing emphasis on pet healthcare. Pet owners are increasingly recognizing the importance of regular veterinary check-ups, vaccinations, and surgical procedures when needed. For these medical interventions, sedation is often required to ensure the safety and comfort of the animals.
The rise in pet ownership has translated into a higher number of visits to veterinary clinics. Whether for routine check-ups, vaccinations, or more complex procedures, these visits require sedation in many cases. Consequently, the increased footfall in veterinary clinics is driving up the demand for animal sedatives.
The pet industry is evolving, with a growing number of specialty veterinary services emerging. These specialties include dermatology, cardiology, dentistry, and even pet rehabilitation. Many of these specialized treatments involve procedures that require sedation. The expanding array of veterinary specialties further drives the demand for a variety of sedatives tailored to specific medical needs.
With the rise of pet ownership, there is also a heightened awareness of pet welfare. Pet owners are more concerned than ever about the well-being and comfort of their animals. This has led to a demand for sedatives that not only ensure the safety of the pet during procedures but also minimize stress and discomfort, aligning with the principles of animal welfare.
As pets live longer, there is an increasing need for geriatric care. Older pets often require more frequent medical attention, including diagnostic procedures and surgeries. Sedation plays a vital role in ensuring that these older animals can undergo necessary medical interventions without undue stress or discomfort.
A growing number of pet owners are seeking solutions for behavioral and anxiety-related issues in their pets. Sedation can be a valuable tool in helping pets cope with anxiety or aggression problems, facilitating behavioral therapy sessions. The demand for sedatives to manage these issues is driving growth in the animal sedative market.
In emerging economies, a rising middle class is contributing to an increase in pet ownership. As these populations grow, so does the demand for pet-related services, including veterinary care. This demographic shift is fostering a global increase in the pet healthcare market, benefiting the animal sedative sector.
Advancements in Veterinary Medicine
The global animal sedative market is witnessing a remarkable surge in demand, thanks to continuous advancements in veterinary medicine. As the field of veterinary medicine continues to evolve, incorporating cutting-edge techniques and technologies, it is also propelling the growth of the animal sedative market.
Advancements in veterinary medicine have led to an increased adoption of minimally invasive surgical procedures. These procedures often require the use of sedatives to ensure that animals remain calm and motionless during surgery. With the rising preference for less invasive approaches, the demand for high-quality animal sedatives has surged.
Veterinarians are increasingly embracing precision medicine, tailoring treatments to individual animals based on their unique needs. This approach requires precise control over anesthesia and sedation to accommodate variations in animal size, breed, and health condition. Advanced sedatives offer veterinarians the flexibility to provide personalized care, thereby driving the growth of the animal sedative market.
Innovations in drug delivery systems have allowed for more precise and controlled administration of sedatives. This not only ensures that the animal receives the right dose but also enables quicker onset and recovery. Veterinarians are now able to provide more efficient care, enhancing the overall experience for both pets and their owners.
Modern veterinary medicine places a strong emphasis on pain management. Animal sedatives play a critical role in this aspect, as they help alleviate pain and reduce stress during procedures. The development of sedatives that are effective in managing pain while maintaining safety has become a key focus, driving demand in the animal sedative market.
Veterinary medicine is diversifying, with specialized services such as oncology, cardiology, neurology, and dentistry becoming more prevalent. Many of these specialized fields require unique sedation protocols tailored to the specific needs of patients. As specialized veterinary services expand, so does the demand for a variety of sedatives.
Advancements in anesthesia monitoring technology have greatly improved the safety and effectiveness of sedation in veterinary medicine. These technologies allow veterinarians to closely monitor vital signs, ensuring the well-being of the animal throughout the procedure. As these monitoring systems become more sophisticated and accessible, they drive the use of sedatives in veterinary practices.
Increasing Awareness of Animal Welfare
In recent years, there has been a significant shift in societal attitudes towards the treatment of animals. As the awareness of animal welfare concerns continues to grow, it is not only reshaping the way we care for our animal companions but also propelling the growth of the global animal sedative market.
Awareness of animal welfare issues has led to a greater emphasis on humane treatment across various sectors, including veterinary medicine. Pet owners and veterinarians are increasingly focused on ensuring that medical procedures, surgeries, and diagnostic tests are conducted with the utmost consideration for the well-being and comfort of the animal. This often involves the use of sedatives to minimize stress and pain during these procedures.
Stress and anxiety can have detrimental effects on an animal's health and recovery process. The awareness of these negative impacts has led to a heightened demand for sedatives that effectively reduce stress and anxiety in animals. As a result, pharmaceutical companies are developing and marketing sedatives designed to provide a calm and stress-free experience for animals, ultimately boosting the animal sedative market.
With increased awareness of animal welfare, there is a growing understanding of the responsibilities that come with pet ownership. Pet owners are more inclined to ensure that their animals receive proper medical care and attention. This includes sedation when necessary, fostering a culture of responsible pet ownership that contributes to the growth of the animal sedative market.
Veterinary organizations and governmental agencies are enacting guidelines and regulations that prioritize the welfare of animals. These regulations often require veterinarians to use sedatives when conducting certain procedures, especially those that may cause distress or pain. Compliance with these regulations drives the demand for sedatives, encouraging market growth.
Animal welfare advocates and veterinarians are increasingly focused on pain management for animals. Sedatives are essential in providing pain relief and reducing suffering during surgeries and other medical procedures. The awareness of the importance of pain management has led to the development of specialized sedatives for this purpose, further fueling market growth.
Animal welfare organizations, including animal shelters and rescue groups, play a vital role in promoting animal welfare. These organizations often require sedatives to manage and treat animals that have experienced trauma or neglect. As the awareness of their efforts grows, so does the demand for sedatives to assist in their work.
Educational campaigns and initiatives focused on animal welfare have reached a broad audience, from schoolchildren to adults. These efforts not only foster empathy and compassion but also educate individuals about the importance of veterinary care and the role of sedation in ensuring the well-being of animals. This education contributes to the long-term growth of the animal sedative market.
Growth in Livestock Production
The livestock industry is a critical component of global agriculture, providing essential resources like meat, milk, and eggs to billions of people worldwide. As livestock production continues to expand to meet the growing demand for animal-based products, it's also contributing to the growth of the global animal sedative market.
Livestock, such as cattle, sheep, and pigs, require various veterinary procedures throughout their lives, including vaccinations, surgeries, and reproductive interventions. Many of these procedures necessitate sedation to ensure the safety of both the animals and the veterinarians. With the global demand for livestock products on the rise, so is the need for animal sedatives.
Stress can have adverse effects on the health and productivity of livestock. High-stress levels can lead to weight loss, reduced fertility, and even disease susceptibility. Animal sedatives help reduce stress during transportation, handling, and medical procedures, contributing to the overall well-being of the animals and the quality of their products.
The welfare of animals in livestock production is an increasing concern. Consumers and regulatory bodies are pushing for better living conditions and humane treatment of livestock. Sedatives are used to manage and alleviate pain and discomfort in animals undergoing surgical or medical interventions, aligning with improved animal welfare standards.
Efforts to maximize livestock productivity have led to the development of advanced breeding and genetics programs. These programs often require reproductive procedures and artificial insemination, which may involve sedation. Sedatives ensure that these procedures are conducted efficiently and safely, contributing to increased livestock productivity.
The growth of the livestock market extends to specialty livestock, such as exotic or high-value animals. These animals may require specialized medical care and sedation for various reasons, including routine health checks, diagnostics, or assisted reproduction. As the demand for specialty livestock rises, so does the need for sedatives.
The expansion of livestock production has spurred the growth of veterinary services specializing in farm animal care. These veterinary practices often provide comprehensive medical care for large numbers of animals, including sedation when necessary. The increased availability of veterinary services for livestock boosts the demand for sedatives.
Key Market Challenges
Ethical Concerns
The ethical concerns associated with animal testing have become a significant issue for the industry. Balancing the need for safety and efficacy testing with the desire to minimize animal suffering is an ongoing challenge. Companies are increasingly exploring alternative testing methods and striving to reduce their reliance on animal testing.
Resistance and Tolerance
Just as in human medicine, animals can develop resistance or tolerance to sedatives over time. This poses challenges for veterinarians who need to adapt treatment protocols or seek alternative sedatives. Manufacturers must continually innovate to develop new sedatives or formulations to combat resistance.
Supply Chain Disruptions
Global events, such as the COVID-19 pandemic, have highlighted vulnerabilities in supply chains. Disruptions in the supply of raw materials or finished products can impact the availability of animal sedatives. Manufacturers must diversify supply sources and implement robust contingency plans to mitigate such disruptions.
Key Market Trends
Advancements in Sedative Formulations
Innovations in pharmaceutical research are leading to the development of safer, more effective, and faster-acting sedatives. These advanced formulations are designed to enhance the overall experience for both animals and veterinarians, reducing procedure times and post-sedation recovery.
Customized Sedation Protocols
Personalized medicine is gaining traction in veterinary care, leading to customized sedation protocols. Veterinarians tailor sedation to individual animal needs, considering factors like age, breed, and health condition. This trend is expected to grow as precision medicine becomes more prevalent.
Alternative Sedation Methods
With concerns over the use of traditional sedatives, there's a growing interest in alternative sedation methods. This includes the use of natural or non-pharmaceutical sedatives, such as herbal remedies or behavioral modification techniques. These alternatives align with the desire for more holistic and natural approaches to animal care.
Segmental Insights
Type Insights
Based on the category of Type, Acepromazine is poised to dominate the Global Animal Sedative Market in 2022 and maintain its stronghold throughout the forecast years for several compelling reasons. Firstly, Acepromazine boasts a long-standing reputation for its efficacy and safety in sedating a wide range of animals, from small pets to large livestock, making it a trusted choice among veterinarians and animal caregivers worldwide. Additionally, the drug's consistent quality and reliable results have earned it the trust of the global veterinary community. Furthermore, Acepromazine's cost-effectiveness compared to alternative sedatives positions it as an attractive option, particularly in regions where cost considerations play a significant role in decision-making. As research and development efforts continue to refine its formulation and delivery methods, Acepromazine is well-positioned to meet evolving market demands, ensuring its dominance in the Global Animal Sedative Market for years to come.
Route of Administration Insights
The Parenteral route of administration is poised to dominate the Global Animal Sedative Market, while oral alternatives are expected to experience substantial growth during the forecast years. Parenteral sedatives, delivered through injections or intravenous means, have long been favored for their immediate and precise effects, making them the preferred choice for critical or emergency situations in veterinary practice. However, oral sedatives are anticipated to grow in popularity due to their ease of administration, reduced stress on animals, and increased convenience for caregivers, particularly for routine procedures and home care. This anticipated growth in the oral segment reflects a shift towards more humane and accessible sedation options for animals, while Parenteral sedatives will continue to hold a strong position in scenarios where rapid sedation is imperative. As the market evolves to accommodate diverse needs, both Parenteral and oral segments are expected to coexist and collectively drive the expansion of the Global Animal Sedative Market.
Regional Insights
North America is poised to maintain a substantial market share in the upcoming forecast period, driven by factors such as the growing adoption of pets and an increase in per capita spending on animal healthcare. Furthermore, the rising incidence of various animal illnesses and injuries is a key catalyst for market expansion. According to the 2020-2021 National Pet Owners Survey conducted by the American Pet Products Association (APPA), there were approximately 69 million dogs and 45.3 million cats in U.S. households. This surge in pet ownership has led North American citizens to become increasingly conscientious about their animals' well-being. Notably, the 2022 State of the Industry Report by the North American Pet Health Insurance Association (NAPHIA) revealed that the total premium volume for pet insurance in the U.S. reached nearly USD 2.6 billion. The number of insured pets in the U.S. grew by 28 percent since 2020, totaling 3.9 million at the end of 2021. With a heightened focus on animal health and expenditure, the market is poised for significant future growth. Furthermore, the market is being propelled by the surge in partnerships, agreements, mergers, and acquisitions among industry players. For example, in November 2022, Noe Animal Hospital expanded its services to offer a comprehensive range of veterinary care in San Francisco and surrounding areas, including wellness check-ups, vaccinations, dental care, and more.
Key Market Players
Zoetis Inc
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Elanco Animal Health Inc
Virbac SA
Dechra Pharmaceuticals PLC
Orion Corporation
Vetoquinol SA
Report Scope:
In this report, the Global Animal Sedative Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Animal Sedative Market.
Available Customizations:
Global Animal Sedative market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
Increasing Pet Ownership
Pet ownership has become a global phenomenon, with millions of households worldwide welcoming furry, feathered, or scaly companions into their lives. This surge in pet ownership is not just about companionship; it's also driving growth in various industries, including veterinary care and pharmaceuticals.
As more people open their homes to pets, there is a growing emphasis on pet healthcare. Pet owners are increasingly recognizing the importance of regular veterinary check-ups, vaccinations, and surgical procedures when needed. For these medical interventions, sedation is often required to ensure the safety and comfort of the animals.
The rise in pet ownership has translated into a higher number of visits to veterinary clinics. Whether for routine check-ups, vaccinations, or more complex procedures, these visits require sedation in many cases. Consequently, the increased footfall in veterinary clinics is driving up the demand for animal sedatives.
The pet industry is evolving, with a growing number of specialty veterinary services emerging. These specialties include dermatology, cardiology, dentistry, and even pet rehabilitation. Many of these specialized treatments involve procedures that require sedation. The expanding array of veterinary specialties further drives the demand for a variety of sedatives tailored to specific medical needs.
With the rise of pet ownership, there is also a heightened awareness of pet welfare. Pet owners are more concerned than ever about the well-being and comfort of their animals. This has led to a demand for sedatives that not only ensure the safety of the pet during procedures but also minimize stress and discomfort, aligning with the principles of animal welfare.
As pets live longer, there is an increasing need for geriatric care. Older pets often require more frequent medical attention, including diagnostic procedures and surgeries. Sedation plays a vital role in ensuring that these older animals can undergo necessary medical interventions without undue stress or discomfort.
A growing number of pet owners are seeking solutions for behavioral and anxiety-related issues in their pets. Sedation can be a valuable tool in helping pets cope with anxiety or aggression problems, facilitating behavioral therapy sessions. The demand for sedatives to manage these issues is driving growth in the animal sedative market.
In emerging economies, a rising middle class is contributing to an increase in pet ownership. As these populations grow, so does the demand for pet-related services, including veterinary care. This demographic shift is fostering a global increase in the pet healthcare market, benefiting the animal sedative sector.
Advancements in Veterinary Medicine
The global animal sedative market is witnessing a remarkable surge in demand, thanks to continuous advancements in veterinary medicine. As the field of veterinary medicine continues to evolve, incorporating cutting-edge techniques and technologies, it is also propelling the growth of the animal sedative market.
Advancements in veterinary medicine have led to an increased adoption of minimally invasive surgical procedures. These procedures often require the use of sedatives to ensure that animals remain calm and motionless during surgery. With the rising preference for less invasive approaches, the demand for high-quality animal sedatives has surged.
Veterinarians are increasingly embracing precision medicine, tailoring treatments to individual animals based on their unique needs. This approach requires precise control over anesthesia and sedation to accommodate variations in animal size, breed, and health condition. Advanced sedatives offer veterinarians the flexibility to provide personalized care, thereby driving the growth of the animal sedative market.
Innovations in drug delivery systems have allowed for more precise and controlled administration of sedatives. This not only ensures that the animal receives the right dose but also enables quicker onset and recovery. Veterinarians are now able to provide more efficient care, enhancing the overall experience for both pets and their owners.
Modern veterinary medicine places a strong emphasis on pain management. Animal sedatives play a critical role in this aspect, as they help alleviate pain and reduce stress during procedures. The development of sedatives that are effective in managing pain while maintaining safety has become a key focus, driving demand in the animal sedative market.
Veterinary medicine is diversifying, with specialized services such as oncology, cardiology, neurology, and dentistry becoming more prevalent. Many of these specialized fields require unique sedation protocols tailored to the specific needs of patients. As specialized veterinary services expand, so does the demand for a variety of sedatives.
Advancements in anesthesia monitoring technology have greatly improved the safety and effectiveness of sedation in veterinary medicine. These technologies allow veterinarians to closely monitor vital signs, ensuring the well-being of the animal throughout the procedure. As these monitoring systems become more sophisticated and accessible, they drive the use of sedatives in veterinary practices.
Increasing Awareness of Animal Welfare
In recent years, there has been a significant shift in societal attitudes towards the treatment of animals. As the awareness of animal welfare concerns continues to grow, it is not only reshaping the way we care for our animal companions but also propelling the growth of the global animal sedative market.
Awareness of animal welfare issues has led to a greater emphasis on humane treatment across various sectors, including veterinary medicine. Pet owners and veterinarians are increasingly focused on ensuring that medical procedures, surgeries, and diagnostic tests are conducted with the utmost consideration for the well-being and comfort of the animal. This often involves the use of sedatives to minimize stress and pain during these procedures.
Stress and anxiety can have detrimental effects on an animal's health and recovery process. The awareness of these negative impacts has led to a heightened demand for sedatives that effectively reduce stress and anxiety in animals. As a result, pharmaceutical companies are developing and marketing sedatives designed to provide a calm and stress-free experience for animals, ultimately boosting the animal sedative market.
With increased awareness of animal welfare, there is a growing understanding of the responsibilities that come with pet ownership. Pet owners are more inclined to ensure that their animals receive proper medical care and attention. This includes sedation when necessary, fostering a culture of responsible pet ownership that contributes to the growth of the animal sedative market.
Veterinary organizations and governmental agencies are enacting guidelines and regulations that prioritize the welfare of animals. These regulations often require veterinarians to use sedatives when conducting certain procedures, especially those that may cause distress or pain. Compliance with these regulations drives the demand for sedatives, encouraging market growth.
Animal welfare advocates and veterinarians are increasingly focused on pain management for animals. Sedatives are essential in providing pain relief and reducing suffering during surgeries and other medical procedures. The awareness of the importance of pain management has led to the development of specialized sedatives for this purpose, further fueling market growth.
Animal welfare organizations, including animal shelters and rescue groups, play a vital role in promoting animal welfare. These organizations often require sedatives to manage and treat animals that have experienced trauma or neglect. As the awareness of their efforts grows, so does the demand for sedatives to assist in their work.
Educational campaigns and initiatives focused on animal welfare have reached a broad audience, from schoolchildren to adults. These efforts not only foster empathy and compassion but also educate individuals about the importance of veterinary care and the role of sedation in ensuring the well-being of animals. This education contributes to the long-term growth of the animal sedative market.
Growth in Livestock Production
The livestock industry is a critical component of global agriculture, providing essential resources like meat, milk, and eggs to billions of people worldwide. As livestock production continues to expand to meet the growing demand for animal-based products, it's also contributing to the growth of the global animal sedative market.
Livestock, such as cattle, sheep, and pigs, require various veterinary procedures throughout their lives, including vaccinations, surgeries, and reproductive interventions. Many of these procedures necessitate sedation to ensure the safety of both the animals and the veterinarians. With the global demand for livestock products on the rise, so is the need for animal sedatives.
Stress can have adverse effects on the health and productivity of livestock. High-stress levels can lead to weight loss, reduced fertility, and even disease susceptibility. Animal sedatives help reduce stress during transportation, handling, and medical procedures, contributing to the overall well-being of the animals and the quality of their products.
The welfare of animals in livestock production is an increasing concern. Consumers and regulatory bodies are pushing for better living conditions and humane treatment of livestock. Sedatives are used to manage and alleviate pain and discomfort in animals undergoing surgical or medical interventions, aligning with improved animal welfare standards.
Efforts to maximize livestock productivity have led to the development of advanced breeding and genetics programs. These programs often require reproductive procedures and artificial insemination, which may involve sedation. Sedatives ensure that these procedures are conducted efficiently and safely, contributing to increased livestock productivity.
The growth of the livestock market extends to specialty livestock, such as exotic or high-value animals. These animals may require specialized medical care and sedation for various reasons, including routine health checks, diagnostics, or assisted reproduction. As the demand for specialty livestock rises, so does the need for sedatives.
The expansion of livestock production has spurred the growth of veterinary services specializing in farm animal care. These veterinary practices often provide comprehensive medical care for large numbers of animals, including sedation when necessary. The increased availability of veterinary services for livestock boosts the demand for sedatives.
Key Market Challenges
Ethical Concerns
The ethical concerns associated with animal testing have become a significant issue for the industry. Balancing the need for safety and efficacy testing with the desire to minimize animal suffering is an ongoing challenge. Companies are increasingly exploring alternative testing methods and striving to reduce their reliance on animal testing.
Resistance and Tolerance
Just as in human medicine, animals can develop resistance or tolerance to sedatives over time. This poses challenges for veterinarians who need to adapt treatment protocols or seek alternative sedatives. Manufacturers must continually innovate to develop new sedatives or formulations to combat resistance.
Supply Chain Disruptions
Global events, such as the COVID-19 pandemic, have highlighted vulnerabilities in supply chains. Disruptions in the supply of raw materials or finished products can impact the availability of animal sedatives. Manufacturers must diversify supply sources and implement robust contingency plans to mitigate such disruptions.
Key Market Trends
Advancements in Sedative Formulations
Innovations in pharmaceutical research are leading to the development of safer, more effective, and faster-acting sedatives. These advanced formulations are designed to enhance the overall experience for both animals and veterinarians, reducing procedure times and post-sedation recovery.
Customized Sedation Protocols
Personalized medicine is gaining traction in veterinary care, leading to customized sedation protocols. Veterinarians tailor sedation to individual animal needs, considering factors like age, breed, and health condition. This trend is expected to grow as precision medicine becomes more prevalent.
Alternative Sedation Methods
With concerns over the use of traditional sedatives, there's a growing interest in alternative sedation methods. This includes the use of natural or non-pharmaceutical sedatives, such as herbal remedies or behavioral modification techniques. These alternatives align with the desire for more holistic and natural approaches to animal care.
Segmental Insights
Type Insights
Based on the category of Type, Acepromazine is poised to dominate the Global Animal Sedative Market in 2022 and maintain its stronghold throughout the forecast years for several compelling reasons. Firstly, Acepromazine boasts a long-standing reputation for its efficacy and safety in sedating a wide range of animals, from small pets to large livestock, making it a trusted choice among veterinarians and animal caregivers worldwide. Additionally, the drug's consistent quality and reliable results have earned it the trust of the global veterinary community. Furthermore, Acepromazine's cost-effectiveness compared to alternative sedatives positions it as an attractive option, particularly in regions where cost considerations play a significant role in decision-making. As research and development efforts continue to refine its formulation and delivery methods, Acepromazine is well-positioned to meet evolving market demands, ensuring its dominance in the Global Animal Sedative Market for years to come.
Route of Administration Insights
The Parenteral route of administration is poised to dominate the Global Animal Sedative Market, while oral alternatives are expected to experience substantial growth during the forecast years. Parenteral sedatives, delivered through injections or intravenous means, have long been favored for their immediate and precise effects, making them the preferred choice for critical or emergency situations in veterinary practice. However, oral sedatives are anticipated to grow in popularity due to their ease of administration, reduced stress on animals, and increased convenience for caregivers, particularly for routine procedures and home care. This anticipated growth in the oral segment reflects a shift towards more humane and accessible sedation options for animals, while Parenteral sedatives will continue to hold a strong position in scenarios where rapid sedation is imperative. As the market evolves to accommodate diverse needs, both Parenteral and oral segments are expected to coexist and collectively drive the expansion of the Global Animal Sedative Market.
Regional Insights
North America is poised to maintain a substantial market share in the upcoming forecast period, driven by factors such as the growing adoption of pets and an increase in per capita spending on animal healthcare. Furthermore, the rising incidence of various animal illnesses and injuries is a key catalyst for market expansion. According to the 2020-2021 National Pet Owners Survey conducted by the American Pet Products Association (APPA), there were approximately 69 million dogs and 45.3 million cats in U.S. households. This surge in pet ownership has led North American citizens to become increasingly conscientious about their animals' well-being. Notably, the 2022 State of the Industry Report by the North American Pet Health Insurance Association (NAPHIA) revealed that the total premium volume for pet insurance in the U.S. reached nearly USD 2.6 billion. The number of insured pets in the U.S. grew by 28 percent since 2020, totaling 3.9 million at the end of 2021. With a heightened focus on animal health and expenditure, the market is poised for significant future growth. Furthermore, the market is being propelled by the surge in partnerships, agreements, mergers, and acquisitions among industry players. For example, in November 2022, Noe Animal Hospital expanded its services to offer a comprehensive range of veterinary care in San Francisco and surrounding areas, including wellness check-ups, vaccinations, dental care, and more.
Key Market Players
Zoetis Inc
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Elanco Animal Health Inc
Virbac SA
Dechra Pharmaceuticals PLC
Orion Corporation
Vetoquinol SA
Report Scope:
In this report, the Global Animal Sedative Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Animal Sedative Market, By Type:
- Acepromazine
- Butorphanol
- Detomidine
- Romifidine
- Xylazine
- Animal Sedative Market, By Route of Administration:
- Oral
- Parenteral
- Animal Sedative Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Company Profiles: Detailed analysis of the major companies present in the Global Animal Sedative Market.
Available Customizations:
Global Animal Sedative market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ANIMAL SEDATIVE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
5.2.2. By Route of Administration (Oral, Parenteral)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Type
5.3.2. By Route of Administration
5.3.3. By Region
6. NORTH AMERICA ANIMAL SEDATIVE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
6.2.2. By Route of Administration (Oral, Parenteral)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Animal Sedative Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Route of Administration
6.3.2. Canada Animal Sedative Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Route of Administration
6.3.3. Mexico Animal Sedative Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Route of Administration
7. EUROPE ANIMAL SEDATIVE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
7.2.2. By Route of Administration (Oral, Parenteral)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Animal Sedative Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Route of Administration
7.3.2. United Kingdom Animal Sedative Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Route of Administration
7.3.3. France Animal Sedative Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Route of Administration
7.3.4. Italy Animal Sedative Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Route of Administration
7.3.5. Spain Animal Sedative Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Route of Administration
8. ASIA-PACIFIC ANIMAL SEDATIVE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
8.2.2. By Route of Administration (Oral, Parenteral)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Animal Sedative Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Route of Administration
8.3.2. Japan Animal Sedative Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Route of Administration
8.3.3. India Animal Sedative Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Route of Administration
8.3.4. Australia Animal Sedative Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Route of Administration
8.3.5. South Korea Animal Sedative Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Route of Administration
9. SOUTH AMERICA ANIMAL SEDATIVE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
9.2.2. By Route of Administration (Oral, Parenteral)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Animal Sedative Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Route of Administration
9.3.2. Argentina Animal Sedative Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Route of Administration
9.3.3. Colombia Animal Sedative Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Route of Administration
10. MIDDLE EAST AND AFRICA ANIMAL SEDATIVE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
10.2.2. By Route of Administration (Oral, Parenteral)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Animal Sedative Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Route of Administration
10.3.2. Saudi Arabia Animal Sedative Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Route of Administration
10.3.3. UAE Animal Sedative Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Route of Administration
10.3.4. Kuwait Animal Sedative Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Route of Administration
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. Zoetis Inc
14.6.2. Boehringer Ingelheim International GmbH
14.6.3. Merck & Co., Inc.
14.6.4. Elanco Animal Health Inc
14.6.5. Virbac SA
14.6.6. Dechra Pharmaceuticals PLC
14.6.7. Orion Corporation
14.6.8. Vetoquinol SA
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ANIMAL SEDATIVE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
5.2.2. By Route of Administration (Oral, Parenteral)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Type
5.3.2. By Route of Administration
5.3.3. By Region
6. NORTH AMERICA ANIMAL SEDATIVE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
6.2.2. By Route of Administration (Oral, Parenteral)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Animal Sedative Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Route of Administration
6.3.2. Canada Animal Sedative Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Route of Administration
6.3.3. Mexico Animal Sedative Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Route of Administration
7. EUROPE ANIMAL SEDATIVE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
7.2.2. By Route of Administration (Oral, Parenteral)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Animal Sedative Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Route of Administration
7.3.2. United Kingdom Animal Sedative Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Route of Administration
7.3.3. France Animal Sedative Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Route of Administration
7.3.4. Italy Animal Sedative Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Route of Administration
7.3.5. Spain Animal Sedative Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Route of Administration
8. ASIA-PACIFIC ANIMAL SEDATIVE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
8.2.2. By Route of Administration (Oral, Parenteral)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Animal Sedative Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Route of Administration
8.3.2. Japan Animal Sedative Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Route of Administration
8.3.3. India Animal Sedative Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Route of Administration
8.3.4. Australia Animal Sedative Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Route of Administration
8.3.5. South Korea Animal Sedative Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Route of Administration
9. SOUTH AMERICA ANIMAL SEDATIVE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
9.2.2. By Route of Administration (Oral, Parenteral)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Animal Sedative Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Route of Administration
9.3.2. Argentina Animal Sedative Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Route of Administration
9.3.3. Colombia Animal Sedative Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Route of Administration
10. MIDDLE EAST AND AFRICA ANIMAL SEDATIVE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
10.2.2. By Route of Administration (Oral, Parenteral)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Animal Sedative Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Route of Administration
10.3.2. Saudi Arabia Animal Sedative Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Route of Administration
10.3.3. UAE Animal Sedative Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Route of Administration
10.3.4. Kuwait Animal Sedative Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Route of Administration
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. Zoetis Inc
14.6.2. Boehringer Ingelheim International GmbH
14.6.3. Merck & Co., Inc.
14.6.4. Elanco Animal Health Inc
14.6.5. Virbac SA
14.6.6. Dechra Pharmaceuticals PLC
14.6.7. Orion Corporation
14.6.8. Vetoquinol SA
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
